Reports
- Polygenic scores for cancer
- Control of patient information in the COVID-19 era
- Implementing polygenic scores for cardiovascular disease into NHS Health Checks
- The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
- Citizen generated data and health: predictive prevention of disease
- Personalising breast cancer prevention – bridging the gap between research and policy
- The GDPR and genomic data
- Artificial intelligence for genomic medicine
- Black box medicine and transparency
- Our healthy future
- Person centred healthcare
- My healthy future: Overdiagnosis
- Privacy and autonomy
- Health technologies and social impacts
- My healthy future: policy context
- The technologies of a healthy future
- Algorithms as medical devices
- Regulating algorithms in healthcare: the GDPR and IVDR in practice
- Polygenic scores, risk and cardiovascular disease
- Personalising prevention for breast cancer
- Dementia risk prediction
- The personalised medicine technology landscape
- Genomics in mainstream clinical pathways
- Identification and genomic data
- Personalised prevention in breast cancer – the policy landscape
- Developing effective ctDNA testing services for lung cancer
- Linking and sharing routine health data for research
- Variant classification and interpretation - workshop report
- Whole exome sequencing in clinical genetics - a health economic evaluation
- Personalised healthcare: bringing the future into focus
- Delivering improved access to genetic testing in epithelial ovarian cancer
- Whole genome sequencing for breast cancer risk testing
- Data sharing to support UK clinical genetics and genomics services
- Pathogen Genomics Into Practice
- Genetic screening programmes: an international review of assessment criteria
- Realising Genomics in Clinical Practice
- A guide to the investigation of intellectual disability and developmental delay in East Anglia
- Enhanced Genetic Services Project
- Stratified Screening for Cancer
- Realising Genomics in Clinical Practice (interim report)
- Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project
- Genomics of obesity
- Beyond the horizon: Connecting science and health
- Genomics in Medicine
- Epidemiology, risk and causation
- Next steps in the sequence
- Quality standards in risk prediction
- Genetics and mainstream medicine: service development and integration
- Public health in an era of genome-based and personalised medicine
- Expanded newborn screening
- Independent response to House of Lords Science and Technology Committee Genomic Medicine report
- Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers
- Tay Sachs Disease carrier screening in the Ashkenazi Jewish population
- Heart to Heart: inherited cardiovascular conditions services
- Cell-free fetal nucleic acids for non-invasive prenatal diagnosis
- Evidence and evaluation: Building public trust in genetic tests for common diseases
- Genetic ophthalmology in focus
- The evaluation of diagnostic laboratory tests and complex biomarkers
- The evaluation of clinical validity and clinical utility of genetic tests
- Family history as a risk factor for common, complex disease
- Moving beyond ACCE: An expanded framework for genetic test evaluation
- Assessment of the Human Tissue Act
- Evaluation of array-CGH for chromosomal abnormalities in clinical practice
- Learning disability: the interface with genetics
- Biomarkers in familial colorectal cancer screening
- Ethical legal and social issues in stem cell research and therapy - 2nd edition
- Metabolic pathways: networks of care
- Evaluation of genetic tests: service development
- Cancer therapeutics in the 'omics' era
- Addressing Genetics, Delivering Health
- Intellectual property rights and genetics
- Pharmacogenetics
- Genetics and health economics workshops
- Genetics and health